Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free GMED Stock Alerts

Globus Medical (GMED) Short Interest Ratio & Short Volume

Globus Medical logo
$83.03 +0.06 (+0.07%)
As of 08/28/2026 03:58 PM Eastern
Compare

Globus Medical Short Interest Overview

As of August 14, 2026, Globus Medical (GMED) had a short interest of 6.80 million shares sold short, representing 6.21% of the public float. This marks a -1.22% decrease in short interest since the prior report. The short interest ratio (days to cover) is 4.0, meaning it would take 4.0 days of the average trading volume of 1.37 million shares to cover all short positions.

Current Short Interest
6,802,529 shares
Previous Short Interest
6,886,644 shares
Change Vs. Previous Month
-1.22%
Dollar Volume Sold Short
$583.32 million
Short Interest Ratio
4.0 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
134,260,000 shares
Short Percent of Float
6.21%
Today's Trading Volume
1,055,379 shares
Average Trading Volume
1,366,896 shares
Today's Volume Vs. Average
77%
Short Selling Globus Medical?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Globus Medical and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GMED Short Interest Over Time

GMED Days to Cover Over Time

GMED Percentage of Float Shorted Over Time

Globus Medical Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/20266,802,529 shares $583.32 million -1.2%6.2%3.95 $85.75
7/31/20266,886,644 shares $543.96 million -2.6%6.2%4.89 $78.99
7/15/20267,069,160 shares $555.18 million -4.6%6.4%3.5 $78.54
6/30/20267,409,990 shares $586.54 million +35.5%6.7%3.56 $79.16
6/15/20265,469,519 shares $422.52 million +39.7%4.9%3.43 $77.25
5/29/20263,916,683 shares $321.16 million +14.7%3.5%1.93 $82.00
5/15/20263,414,228 shares $261.24 million +9.4%3.1%1.62 $76.52
4/30/20263,120,512 shares $281.36 million -5.8%2.8%3.52 $90.17
4/15/20263,313,920 shares $312.98 million +17.1%3.0%2.9 $94.45
3/31/20262,831,226 shares $244.24 million -14.1%2.6%2.86 $86.27
3/13/20263,293,919 shares $279.35 million +0.7%3.0%3.33 $84.81
2/27/20263,270,517 shares $311.98 million -30.1%3.0%2.3 $95.39
2/13/20264,675,619 shares $411.68 million +13.4%4.2%3.94 $88.05
1/30/20264,124,408 shares $374.13 million +6.4%3.8%3.74 $90.71
1/15/20263,875,375 shares $363.73 million -9.1%3.6%1.9 $93.86
12/31/20254,262,628 shares $372.51 million +4.0%3.9%3.61 $87.39
12/15/20254,097,040 shares $354.37 million -6.8%3.8%2.69 $86.50
11/28/20254,397,222 shares $400.32 million -8.9%4.0%2.55 $91.04
11/14/20254,824,835 shares $406.90 million -32.5%4.4%1.49 $84.34
10/31/20257,150,376 shares $432.64 million +12.9%6.5%5.71 $60.51
10/15/20256,330,000 shares $369.39 million +3.4%5.8%4.8 $58.36
9/30/20256,120,000 shares $350.68 million -7.1%N/A4.3 $57.30
9/15/20256,590,000 shares $383.37 million +14.4%N/A4.6 $58.18
8/31/20255,760,000 shares $352.83 million +5.9%5.2%4.1 $61.26
8/15/20255,440,000 shares $329.83 million +13.8%N/A3.9 $60.63
7/31/20254,780,000 shares $251.49 million +5.8%4.3%2.8 $52.61
7/15/20254,520,000 shares $252.49 million +4.9%N/A2.8 $55.86
6/30/20254,310,000 shares $254.20 million -7.1%3.9%2.9 $58.98
6/15/20254,640,000 shares $273.06 million -10.1%4.2%3.2 $58.85
5/31/20255,160,000 shares $305.37 million +14.4%4.7%3.4 $59.18
5/15/20254,510,000 shares $260.50 million +6.9%4.1%2.9 $57.76
4/30/20254,220,000 shares $303.04 million -0.5%N/A2.9 $71.81
4/15/20254,240,000 shares $306.49 million +28.5%3.8%3.4 $72.29
3/31/20253,300,000 shares $241.49 million +36.4%3.0%2.4 $73.18
3/15/20252,420,000 shares $172.32 million -7.6%2.2%1.9 $71.21
2/28/20252,620,000 shares $210.49 million +12.9%2.4%2.3 $80.34
2/15/20252,320,000 shares $194.86 million +6.4%2.1%2.1 $83.99
1/31/20252,180,000 shares $202.09 million -12.8%N/A1.9 $92.70
1/15/20252,500,000 shares $226.40 million +0.4%N/A2.4 $90.56
12/31/20242,490,000 shares $205.95 million +4.6%N/A2.6 $82.71
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
12/15/20242,380,000 shares $196.16 million -2.5%N/A2.7 $82.42
11/30/20242,440,000 shares $208.89 million -12.5%N/A3 $85.61
11/15/20242,790,000 shares $226.27 million -2.5%N/A3.5 $81.10
10/31/20242,860,000 shares $210.32 million +0.7%N/A3.5 $73.54
10/15/20242,840,000 shares $210.30 million -16.7%N/A3.5 $74.05
9/30/20243,410,000 shares $243.95 million -3.4%N/A4.3 $71.54
9/15/20243,530,000 shares $246.22 million -19.6%N/A4.1 $69.75
8/31/20244,390,000 shares $319.15 million No ChangeN/A4.8 $72.70
8/15/20244,390,000 shares $301.99 million -9.1%N/A4.6 $68.79
7/31/20244,830,000 shares $347.86 million -29.0%N/A4.6 $72.02
7/15/20246,800,000 shares $489.87 million -5.0%N/A6.7 $72.04
6/30/20247,160,000 shares $490.39 million +4.4%N/A7 $68.49
6/15/20246,860,000 shares $450.08 million -2.6%N/A6.6 $65.61
5/31/20247,040,000 shares $472.45 million -2.0%N/A6.5 $67.11
5/15/20247,180,000 shares $463.61 million -20.1%N/A6.5 $64.57
4/30/20248,990,000 shares $447.61 million +19.7%N/A8 $49.79
4/15/20247,510,000 shares $389.09 million -3.2%N/A7.2 $51.81
3/31/20247,760,000 shares $416.25 million +32.4%N/A6.7 $53.64
3/15/20245,860,000 shares $301.26 million +2.3%N/A5.1 $51.41
2/29/20245,730,000 shares $309.36 million -0.9%N/A4.8 $53.99
2/15/20245,780,000 shares $309.40 million +8.7%N/A4.7 $53.53
1/31/20245,320,000 shares $280.66 million +55.1%N/A4.3 $52.76
1/15/20243,430,000 shares $192.83 million No ChangeN/A2.6 $56.22
12/31/20233,430,000 shares $182.78 million +0.9%N/A2.7 $53.29
12/15/20233,400,000 shares $168.44 million +6.3%N/A2.6 $49.54
11/30/20233,200,000 shares $143.74 million -13.0%N/A2.3 $44.92
11/15/20233,680,000 shares $168.58 million -7.8%N/A1.8 $45.81
10/31/20233,990,000 shares $182.38 million -6.3%N/A2 $45.71
10/15/20234,260,000 shares $226.29 million -4.1%N/A2.3 $53.12
9/30/20234,440,000 shares $220.45 million +3.0%N/A2.5 $49.65
9/15/20234,310,000 shares $215.59 million -59.2%N/A2.6 $50.02
8/31/202310,570,000 shares $572.31 million +32.6%N/A6.8 $54.15
8/15/20237,970,000 shares $455.09 million -1.5%10.3%9.3 $57.10
7/31/20238,090,000 shares $487.42 million -1.6%10.5%8.7 $60.25
7/15/20238,220,000 shares $509.23 million +3.9%10.6%7.6 $61.95
6/30/20237,910,000 shares $470.96 million +2.3%10.2%7 $59.54
6/15/20237,730,000 shares $453.98 million -3.9%10.0%6.2 $58.73
5/31/20238,040,000 shares $435.21 million +4.4%10.4%5.9 $54.13
5/15/20237,700,000 shares $436.28 million +24.0%10.0%5.3 $56.66
4/30/20236,210,000 shares $361.05 million +7.4%8.0%3.5 $58.14
4/15/20235,780,000 shares $332.58 million +13.1%7.5%3.7 $57.54
3/31/20235,110,000 shares $289.43 million +12.8%6.6%3.4 $56.64
3/15/20234,530,000 shares $237.87 million +17.1%5.9%3.4 $52.51
2/28/20233,870,000 shares $225.78 million +50.0%5.0%3.4 $58.34
2/15/20232,580,000 shares $158.57 million -47.4%3.3%2.5 $61.46
1/31/20234,900,000 shares $369.95 million +1.0%6.4%6.4 $75.50
1/15/20234,850,000 shares $360.84 million +2.1%6.3%8.5 $74.40
12/30/20224,750,000 shares $352.78 million -5.6%6.2%8.1 $74.27
12/15/20225,030,000 shares $363.92 million -15.2%6.6%8.6 $72.35
11/30/20225,930,000 shares $438.17 million +2.4%7.7%9.5 $73.89
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
11/15/20225,790,000 shares $415.61 million +7.6%7.5%9.4 $71.78
10/31/20225,380,000 shares $360.46 million +9.4%N/A9.4 $67.00
10/15/20224,920,000 shares $298.99 million +0.6%N/A8.4 $60.77
9/30/20224,890,000 shares $291.30 million +1.0%N/A8.3 $59.57
9/15/20224,840,000 shares $297.71 million -7.5%N/A8 $61.51
8/31/20225,230,000 shares $309.56 million +0.8%N/A8.3 $59.19
8/15/20225,190,000 shares $350.53 million +3.0%N/A8.3 $67.54
7/31/20225,040,000 shares $295.80 million +1.4%6.7%7.1 $58.69
7/15/20224,970,000 shares $280.01 million +5.1%6.6%6.1 $56.34
6/30/20224,730,000 shares $265.54 million +2.2%6.3%5.4 $56.14
6/15/20224,630,000 shares $257.34 million +2.7%6.2%5.3 $55.58
5/31/20224,510,000 shares $300.37 million +2.5%N/A5.4 $66.60
5/15/20224,400,000 shares $279.80 million +30.6%N/A5.2 $63.59
4/30/20223,370,000 shares $223.16 million -13.8%N/A4.3 $66.22
4/15/20223,910,000 shares $303.03 million +51.0%N/A5.5 $77.50
3/31/20222,590,000 shares $191.09 million +14.6%N/A4.4 $73.78
3/15/20222,260,000 shares $148.91 million +137.5%N/A4.2 $65.89
2/28/2022951,500 shares $66.91 million -25.7%N/A1.7 $70.32
2/15/20221,280,000 shares $88.64 million +34.1%N/A2.4 $69.25
1/31/2022954,600 shares $63.70 million +27.8%N/A1.8 $66.73
1/15/2022747,000 shares $54.87 million -19.8%N/A1.5 $73.45
12/31/2021931,300 shares $67.24 million -9.6%N/A1.9 $72.20
12/15/20211,030,000 shares $68.95 million +27.4%N/A2.1 $66.94
11/30/2021808,400 shares $50.62 million +3.4%N/A1.8 $62.62
11/15/2021782,200 shares $55.37 million -31.4%N/A1.7 $70.79
10/29/20211,140,000 shares $87.97 million -14.9%N/A2.7 $77.17
10/15/20211,340,000 shares $102.42 million +14.5%1.7%3.2 $76.43
9/30/20211,170,000 shares $89.65 million +1.7%1.5%2.7 $76.62
9/15/20211,150,000 shares $93.29 million +0.9%1.5%2.5 $81.12
8/31/20211,140,000 shares $93.02 million -1.7%1.5%2.7 $81.60

GMED Short Interest - Frequently Asked Questions

Short interest is the volume of Globus Medical shares that have been sold short but have not yet been closed out or covered. As of August 14th, investors have sold 6,802,529 shares of GMED short. 6.21% of Globus Medical's shares are currently sold short. Learn More on Globus Medical's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMED shares currently have a short interest ratio of 4.0. Learn More on Globus Medical's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.21% of Globus Medical's floating shares are currently sold short.

Globus Medical saw a decline in short interest during the month of August. As of August 14th, there was short interest totaling 6,802,529 shares, a decline of 1.2% from the previous total of 6,886,644 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.21% of Globus Medical's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare equipment" compare to Globus Medical: IDEXX Laboratories, Inc. (2.48%), DexCom, Inc. (4.39%), GE HealthCare Technologies Inc. (3.87%), ResMed Inc. (8.93%), Koninklijke Philips N.V. (0.25%), STERIS plc (2.40%), Zimmer Biomet Holdings, Inc. (4.67%), Baxter International Inc. (4.63%), Penumbra, Inc. (4.76%), Smith & Nephew SNATS, Inc. (1.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling GMED is an investing strategy that aims to generate trading profit from Globus Medical as its price is falling. GMED shares are trading up $0.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Globus Medical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMED, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMED, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GMED:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NYSE:GMED is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel